Biotech · Private company
Tasly Pharmaceuticals, Inc.
Track this companyFree. Adds Tasly Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- T89 capsulePhase 3 · Acute Mountain Sickness (AMS)ClinicalTrials.gov · fetched Nov 12, 2026
- T89 capsulePhase 3 · Chronic Stable Angina PectorisClinicalTrials.gov · fetched Nov 12, 2026
- T89 capsuleCovid19ClinicalTrials.gov · fetched Nov 12, 2026
- T92Tourette Syndrome in ChildrenClinicalTrials.gov · fetched Nov 12, 2026
- TSupport (a Traditional Chinese Medicine)Tourette SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette SyndromeNA · UNKNOWN · started May 1, 2022ClinicalTrials.gov NCT05188274 · fetched Nov 12, 2026
- Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette SyndromeNA · UNKNOWN · started Mar 1, 2022ClinicalTrials.gov NCT05183594 · fetched Nov 12, 2026
- Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)PHASE3 · COMPLETED · started Jul 21, 2021ClinicalTrials.gov NCT04993729 · fetched Nov 12, 2026
- Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable AnginaPHASE3 · RECRUITING · started Aug 1, 2019ClinicalTrials.gov NCT03789552 · fetched Nov 12, 2026
- Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)PHASE2 · COMPLETED · started Jun 7, 2018ClinicalTrials.gov NCT03552263 · fetched Nov 12, 2026
- Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19NO_LONGER_AVAILABLEClinicalTrials.gov NCT04646031 · fetched Nov 12, 2026